BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Immunophilins

Below is an extended Immunophilins research listing. Click here to return to the Immunophilins main in depth entry.

Recent Publications on Immunophilins:

Computational anti-AIDS drug design based on the analysis of the specific interactions between immunophilins and the HIV-1 gp120 V3 loop. Application to the FK506-binding protein. 24th September, 2008
Institute of Bioorganic Chemistry, National Academy of Sciences of
Kaempferol: a new immunosuppressant of calcineurin.
Calcineurin (CN), the Ca(2+)/calmodulin (CaM)-dependant protein...
Direct Link
23rd September, 2008
Department of Biochemistry and Molecular Biology, Beijing Normal
Modulation of P-glycoproteins by auxin transport inhibitors is mediated by interaction with immunophilins.
The immunophilin-like FKBP42 TWISTED DWARF1 (TWD1) has been shown to...
Direct Link
23rd September, 2008
Institute of Plant Biology and Zurich-Basel Plant Science Center,
Spliceosomal immunophilins.
The spliceosome is a dynamic, macromolecular complex, which removes...
Direct Link
9th September, 2008
Florida International University, Department of Biological Sciences,
Pharmacodynamic monitoring of calcineurin phosphatase activity in transplant patients treated with calcineurin inhibitors. 8th August, 2008
Department of Clinical Pharmacy and Education, Graduate School of
A novel FK506-like binding protein (FKBPL) interacts with the glucocorticoid receptor and regulates steroid receptor signalling.
FKBPL is a novel immunophilin-like protein that plays a role in the...
Direct Link
2nd August, 2008
School of Pharmacy, Queen's University, 97 Lisburn Road, Belfast, Northern
FKBP Family Proteins: Immunophilins with Versatile Biological Functions.
Immunophilins consist of a family of highly conserved proteins binding...
Direct Link
19th July, 2008
School of Biological Science, Nanyang Technological University, Singapore,
Analysis of FK506-mediated protection in an organotypic model of spinal cord damage: heat shock protein 70 levels are modulated in microglial cells.
Functional loss after spinal cord injuries is originated by primary and...
Direct Link
26th June, 2008
Group of Neuroplasticity and Regeneration, Institute of Neurosciences and
Membrane association of the Arabidopsis ARF exchange factor GNOM involves interaction of conserved domains.
The GNOM protein plays a fundamental role in Arabidopsis thaliana...
Direct Link
16th May, 2008
Center of Molecular Biology of Plants, University of Tubingen, 72076
FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway. 7th May, 2008
Hermelin Brain Tumor Center, Department of Neurosurgery, Henry Ford
Pharmacological neuroprotective therapy for acute spinal cord injury: state of the art. 26th April, 2008
Unidad de Investigacion Medica en Enfermedades Neurologicas, HE, CMN Siglo
Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury.
Advances in the neurobiology of growth factors, neural development, and...
Direct Link
19th April, 2008
The Ottawa Hospital, Civic Campus, B3-Division of Urology, Ottawa K1Y 4E9,
Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.
Cell-free human T-lymphotropic virus type 1 (HTLV-1) virions are poorly...
Direct Link
17th April, 2008
Basic Research Program, Science Applications International
Neuroprotective and antiretroviral effects of the immunophilin ligand GPI 1046.
HIV infection results in a neurodegenerative disorder for which currently...
Direct Link
26th February, 2008
Department of Neurology, The Johns Hopkins University School of Medicine
Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities.
Rapamycin is an immunosuppressive immunophilin ligand reported as having...
Direct Link
6th February, 2008
Chemical and Screening Sciences, Wyeth Research, 401 North Middletown
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional